Hepsin inhibits CDK11p58 IRES activity by suppressing unr expression and eIF-2alpha phosphorylation in prostate cancer
Hepsin inhibits CDK11p58 IRES activity by suppressing unr expression and eIF-2alpha phosphorylation in prostate cancer
复制标题
Hepsin 通过抑制前列腺癌中 unr 表达和 eIF-2α 磷酸化来抑制 CDK11p58 IRES 活性
DOI:
10.1016/j.cellsig.2014.12.020
复制
发表时间:
2015
影响因子:
4.8
通讯作者:
Gu Jianxin
中科院分区:
文献类型:
--
作者:
Zhang Chunyi;Zhang Mingming;Wu Qingyu;Peng Jianhao;Ruan Yuanyuan;Gu Jianxin
Hepsin is a type II transmembrane serine protease frequently overexpressed in prostate cancer (PCa). However, the role of hepsin in PCa remains unclear. In this study, we found that hepsin inhibited the internal ribosome entry site (IRES) activity and expression of CDK11p58, which is associated with cell cycle progression and pro-apoptotic signaling in PCa. Hepsin suppressed CDK11p58 IRES activity in PCa by modulating unr expression and eIF-2α phosphorylation. Further studies revealed that hepsin inhibited the expression of unr by directly binding to unr IRES element and suppressing its activity, and also repressed eIF-2α phosphorylation through down-regulating the expression and phosphorylation of general control non-derepressible-2 (GCN2). Taken together, our data suggest a novel role of hepsin in regulating CDK11p58 IRES activity, and imply that hepsin may act on the machinery of translation to modulate cell cycle progression and survival in PCa cells.